The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Teva Pharmaceutical Industries Ltd (TEVA)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Seven New ETF Opportunities

Oct 12, 2008 02:55 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

Seven New ETF Opportunities


The accompanying tables present an overview of new global equity indexes and ETF proposals I have developed to provide investors with access to six industry groups and one geographic region that currently have no investment products on the market. Of these ideas, only the Nordic Region has a pending ETF filed with the SEC. The goal of these ideas is to provide investors with global equity index investment products which are more focused than broad-based ETFs such as iShares Dow Transports (IYT), Healthcare Sector SPDR (XLV), and Consumer Staples Sector SPDR (XLP).

However, the goal is to choose industry groups which are not too narrowly focused and have the potential to attract widespread investor interest. Some investment themes behind these industry groups include: pricing power for rail transport, high dividend yields + defensive nature of tobacco, global consolidation of generic drug industry, improved patient care + cost-savings for health info tech, and widespread weakness + high volatility in the airline + auto industries with the potential for a short/inverse ETF.


Global Passenger Airline Index
Global Auto Industry Index
Global Generic Drug Index
Global Health Info Tech
NordiCaps PerformIdex
Global Railroad Index
Global Tobacco Index


TEVA:  This call was made on 10/12/08 @ $39.93
Rating:   Positive   $39.93 (10/12/08)
Closed:   10/15/2008 @ $38.74 (-2.98% in 3 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +35.25% 368
2 18.14 +70.90% 206
3 17.66 +25.78% 53
4 13.47 +14.32% 60
5 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Teva Pharmaceutical Industries Ltd (TEVA)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
76.5%
Top:
75.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
EXAS Positive -0.76% 11/07/09
NFES N/A Positive n/a 11/07/09
IMUC N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -0.53% 11/04/09

View All >
   
Mike Havrilla previously rated TEVA
Positive +3.70% New Stock Indexes to Track Trends in Healthcare Sector
10/28/2009
9
Positive +10.50% FDA, Clinical Trial Calendar Updates: THRX, GILD, TEVA, ALNY, RNUGF
04/06/2009
9
Positive +1.69% Momenta Pharma's Three-Part Strategy
03/06/2009
9
Positive -1.84% Big Pharma Goes Generic
02/26/2009
9
Positive -0.09% Caraco Pharma Awaits FDA Inspection in May
02/25/2009
9
Positive -2.89% A 130/30 Pharma Trade
02/20/2009
9
Positive +9.58% New Website for Healthcare Investors and Traders
02/10/2009
9
Positive +0.78% Healthcare Investing Trends in '09 and Beyond
02/07/2009
9
Positive +0.00% Healthcare Investing Trends in '09 and Beyond
02/07/2009
9
Positive -1.86% A New Global Healthcare Composite Index
01/13/2009
9
Positive +1.51% Caraco Pharma: Defensive Growth at a Value Price
12/02/2008
9
Positive +3.88% Stock Picks for a 'Roadhouse Blues' Market
11/21/2008
9
Positive -0.68% A New Index of Healthcare Cost Containment Companies
11/20/2008
9
Positive +1.24% Teva Beats on Profits: A Biogeneric Boon in '09?
11/06/2008
9
Positive -4.98% A Bullish Outlook for Generic Drugs After Election
11/04/2008
9
Positive +5.39% Updated FDA Calendar of 72 Decision Dates
10/30/2008
9
Positive +1.74% Teva is on Target to Acquire Barr
10/29/2008
9
Positive -1.39% Expanding Defensive Growth Index into Europe
10/22/2008
9
Positive +4.00% Generic Drug Industry Outpaces Drug & Healthcare ETFs
10/15/2008
9
Positive -11.76% Pfizer is a Big Pharma Buy
09/24/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch